DOSE-ADJUSTED EPOCH-R: A RETROSPECTIVE STUDY IN THE TREATMENT OF AGGRESSIVE LYMPHOMAS

被引：0
|
作者：
Anichini, M. [1 ]
Kovalchuk, S. [1 ]
Puccini, B. [1 ]
Romano, I. [1 ]
Mazzoni, C. [1 ]
Galli, E. [1 ]
Bosi, A. [1 ]
机构：
[1] Azienda Osped Univ Careggi, SOD Ematol, Florence, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU35
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [1] Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas
    Lakhotia, Rahul
    Melani, Christopher
    Dunleavy, Kieron
    Pittaluga, Stefania
    Desai, Sanjal
    Ahlman, Mark A.
    Lucas, Nicole
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Wilson, Wyndham H.
    Roschewski, Mark
    LEUKEMIA & LYMPHOMA, 2025,
  • [2] Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas
    Desai, Sanjal
    Melani, Christopher
    Dunleavy, Kieron
    Pittaluga, Stefania
    Ahlman, Mark A.
    Lucas, Andrea Nicole
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Roschewski, Mark
    Wilson, Wyndham
    BLOOD, 2019, 134
  • [3] Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap?
    Weis, Taylor M.
    Perissinotti, Anthony J.
    Nachar, Victoria R.
    Brown, Anna M.
    Phillips, Tycel J.
    Marini, Bernard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2952 - +
  • [4] Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap? Reply
    Bartlett, Nancy L.
    Wilson, Wyndham H.
    Leonard, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2953 - +
  • [5] Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas
    Gharwan, Helen
    Lai, Catherine
    Grant, Cliona
    Dunleavy, Kieron
    Steinberg, Seth M.
    Shovlin, Margaret
    Fojo, Tito
    Wilson, Wyndham H.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1616 - 1624
  • [6] Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2
    Godfrey, James K.
    Nabhan, Chadi
    Karrison, Theodore
    Kline, Justin P.
    Cohen, Kenneth S.
    Bishop, Michael R.
    Stadler, Walter M.
    Karmali, Reem
    Venugopal, Parameswaran
    Rapoport, Aaron P.
    Smith, Sonali M.
    CANCER, 2019, 125 (11) : 1830 - 1836
  • [7] The role of rituximab and chemotherapy in aggressive B-cell lymphoma: A preliminary report of dose-adjusted EPOCH-R
    Wilson, WH
    Gutierrez, M
    O'Connor, P
    Frankel, S
    Jaffe, E
    Chabner, BA
    Grossbard, ML
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 41 - 47
  • [8] Evaluation of Dose-Adjusted EPOCH-R Compared with R-CHOP for the Treatment of High-Risk, Aggressive B-Cell Lymphomas: A Single-Center Experience
    Rockwell, Sarah J.
    Richter, Katherine A.
    Caddell, Ryan J.
    Chavez, Julio C.
    BLOOD, 2020, 136
  • [9] Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH)
    Igor Aurer
    Sandra Bašić-Kinda
    Ivo Radman
    Ivana Ilić
    Josip Joachim Grah
    Annals of Hematology, 2014, 93 : 177 - 178
  • [10] Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH)
    Aurer, Igor
    Basic-Kinda, Sandra
    Radman, Ivo
    Ilic, Ivana
    Grah, Josip Joachim
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 177 - 178
12345